Support the fact-based journalism you rely on with a donation to Marketplace today. Give Now!

Why Pfizer says it pushed for transparency and diversity in vaccine development process

Nov 9, 2020
To build public trust, Pfizer shared details of their trials: who was tested, the race and ethnicity of participants, how they were monitored, how to measure success and funding sources.
A person walks by Pfizer headquarters on Nov. 9, 2020, in New York City. Transparency is key for a vaccine-skeptical public.
David Dee Delgado/Getty Images